Demonstrating non-inferiority of bio-fluorescent particle counter (BFPC) technology to traditional active air-sampling methods is essential for implementation. Here's how to approach it.
- The Missing Layer: Why CAR-T Needs AI As Its Connective Tissue
- Building A Self-Driving Lab For LNP Development
- Unlocking Gentler, Cost-Efficient TIL Therapy For Cold Tumors
- Full FDA Approval For TECELRA Marks More Than A Regulatory Win For Solid Tumors
- Addressing The Particulate Challenge In Cell Therapy Products
- Let's Stop Treating Allogeneic Cell Therapy As One Thing
- Allogeneic Cell Therapy Is Still Learning What Biology Will Allow
- Reassessing Nanoparticle Immunotoxicity: From Well-Established To Novel Approaches
CELL & GENE ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
![Drug Safety GettyImages-1265108955]( "Optimizing Safety Measures For rAAV Therapies")
Optimizing Safety Measures For rAAV TherapiesExplore common process-related impurities found in recombinant Adeno-Associated Virus (rAAV) vectors and the analytical testing methods used for these residuals.
-
![Global logistics supply chain-GettyImages-2256982707]( "An Innovative, Modular Approach To Flexible Supply Chain Management")
An Innovative, Modular Approach To Flexible Supply Chain ManagementLearn how modular strategies, global coordination, and data-driven decisions help maintain continuity, compliance, and speed amid constant uncertainty.
-
![GettyImages-1583149311 biomanufacturing, automation, robotics]( "Enhancing Preclinical Cell Therapy Development")
Enhancing Preclinical Cell Therapy DevelopmentAutomation in cell therapy development boosts reproducibility, reduces error, and enhances yield. Learn how it’s reshaping preclinical workflows and accelerating clinical trial readiness.
-
![GettyImages-1293879301-scientists-inspecting-analyzing-lab]( "Improved Sensitivity In Flow Cytometry By In-Line Pre-Enrichment")
Improved Sensitivity In Flow Cytometry By In-Line Pre-EnrichmentTracking rare immune cells is no longer limited by conventional flow cytometry sensitivity. Learn how integrated pre‑enrichment strategies enable reliable detection and improved quantification.
-
![clinical-compliance-GettyImages-2259718661]( "10 Clinical Research Practices That Feel Like Compliance (But Aren't)")
10 Clinical Research Practices That Feel Like Compliance (But Aren't)Many clinical research routines are driven by habit, not regulation. This guide clears up 10 common misconceptions to streamline workflows and reduce unnecessary admin work.
-
![Cancer patient consulting with doctor-GettyImages-1217056000]( "Accelerating Approval Pathway For Phase III Ovarian Cancer Trial")
Accelerating Approval Pathway For Phase III Ovarian Cancer TrialA late-stage biotech developing a first-in-class therapy for a rare, chemo-resistant form of ovarian cancer sought help for accelerated FDA approval.
-
![GettyImages-1931925757-assay-well-plate-pipette-red-liquid]( "Flow Cytometric Analysis: Differentiation Potential Of Human Stem Cells")
Flow Cytometric Analysis: Differentiation Potential Of Human Stem CellsExplore an assay kit that simplifies handling with a methylcellulose-free medium and clear flow cytometric readout, which enhances automation and high-throughput sample acquisition for versatile research.
-
![GettyImages-1396008671 RNA, DNA sequencing]( "Epigenetics Application Guide: RNA Modifications")
Epigenetics Application Guide: RNA ModificationsLearn about the rapidly evolving field of RNA modifications, including innovative techniques like miCLIP and RIP for mapping chemical modifications and understanding RNA’s role in cellular processes.
-
![GettyImages-1600719545 lab]( "Why Biopharma Breakthroughs Aren't Moving The Market")
Why Biopharma Breakthroughs Aren't Moving The MarketBiopharma is innovating fast but falling short commercially. Reveal key ecosystem gaps and five strategic actions to help strengthen resilience, accelerate performance, and futureproof organizations.
-
![Emulate Liver Chip]( "A Human-Relevant Model Of The Liver Sinusoid")
A Human-Relevant Model Of The Liver SinusoidThis organ-on-a-chip model minimizes drug absorption while maintaining the essential architecture. Explore the specifications of this product engineered to model the human liver.
NEWSLETTER ARCHIVE
- 07.22.26 -- Accelerate Your Gene Therapy Pipeline with NGS, AAV Clearance, and Virus Bank Expertise
- 07.22.26 -- Wondering If Your Org Should Purchase R&D Datasets?
- 07.21.26 -- How To Match CGT Manufacturing Models To Pipeline Needs
- 07.21.26 -- Exploring Dendritic Cell Therapy for Solid Tumors With Diakonos Oncology's Jay Hartenbach
- 07.20.26 -- Mapping Early-Phase Supply Chain Bottlenecks That Doom Pipelines
- Solving Vector Yield Challenges Starts Long Before Manufacturing
- Full FDA Approval For TECELRA Marks More Than A Regulatory Win For Solid Tumors
- FDA Approval Of TREGZI Signals A New Era For Precision Engineered Cell Therapy
- How CGT Developers Should Think About Manufacturing Models, Hybrid Strategies, And Scale
- In Vivo Gene Editing Is Moving From Promise To Proof
CELL AND GENE CONTENT COLLECTIONS
While there are opportunities to scale, there are also manufacturing gaps, capacity issues, and production timelines that require improvement to do so. And then, of course, there’s cost. Because scale up and scale out are significant to everyone in the sector, we’ve curated insightful editorial that addresses the most important aspects of scalability.
More Content Collections
